Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersResearch in context
Summary: Background: The emergence of potentially effective new therapies for genetic forms of amyotrophic lateral sclerosis (ALS) necessitates the identification of biomarkers to facilitate early treatment, prior to the onset of motor symptoms. Here, we sought to investigate whether metabolic alte...
Main Authors: | Johannes Dorst, Patrick Weydt, David Brenner, Simon Witzel, Katharina Kandler, André Huss, Christine Herrmann, Maximilian Wiesenfarth, Antje Knehr, Kornelia Günther, Kathrin Müller, Jochen H. Weishaupt, Johannes Prudlo, Karin Forsberg, Peter M. Andersen, Angela Rosenbohm, Joachim Schuster, Francesco Roselli, Luc Dupuis, Benjamin Mayer, Hayrettin Tumani, Jan Kassubek, Albert C. Ludolph |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423000865 |
Similar Items
-
Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers
by: Mica T. M. Clarke, et al.
Published: (2021-02-01) -
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
by: Lorenzo Gaetani, et al.
Published: (2021-05-01) -
Actionability and scope should determine the extent of counselling for presymptomatic genetic testing
by: Bettina Zimmermann, et al.
Published: (2020-06-01) -
Disease-related cortical thinning in presymptomatic granulin mutation carriers
by: Sergi Borrego-Écija, et al.
Published: (2021-01-01) -
Quantifying the presymptomatic transmission of COVID-19 in the USA
by: Luyu Zhang, et al.
Published: (2024-01-01)